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Fibrin glue, a two-component tissue adhesive, has a range of clinical indications. Bioactive glass (BG)
S53P4 has been approved for clinical use in several craniomaxillofacial and orthopedic applications.
Although sometimes used simultaneously, there is no data available regarding the possible interaction of
these two biocompatible substances. In this in vitro study, using a BG particle concentration of 4 mg/ml, a
0.4 unit pH increment (p < 0.001) was observed in simulated body ﬂuid (SBF) after a 7-day incubation
period. The addition of ﬁbrin glue (0.13 g, SD 0.04; or 3.7 mg/ml) on top of the BG particles raised further
the pH by 0.5 units (p < 0.001). The difference between these groups was statistically signiﬁcant
(p ¼ 0.008). With a BG concentration of 25 mg/ml and a ﬁbrin glue concentration of 18 mg/ml during a
14-day incubation period, a pH increment of 0.6 units and SBF ion concentration change of Ca, K, Mg, Na,
P and Si ions was seen. Moreover, a penetration depth between 4 and 6 mm was observed when ﬁbrin
glue was applied on top of a bed of BG particles. Conclusions: Fibrin glue is not likely to have a distracting
effect on BG-induced pH increase of the SBF although it might delay early BG surface reactions based on
ion concentration measurements. Fibrin glue penetrated to the interparticle space to some extent,
binding the particles together for easy clinical use of BG.
© 2016 The Authors. Publishing services by Elsevier B.V. on behalf of Vietnam National University, Hanoi.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
Fibrin sealant or ﬁbrin glue, is a two-component tissue adhesive
consisting of ﬁbrinogen and thrombin. It has a variety of clinical
indications including hemostasis, colonic sealing and skin graft
attachment [1]. Additional, clinical and experimental uses are being
continuously developed, and the current literature on ﬁbrin sealant
exceeds 4900 indexed articles.
Various types of bioactive glass (BG) and bioactive glass ce-
ramics have been in clinical use since the 1980's [2,3]. BG S53P4 has
been approved for clinical use in Europe (European conformity CE-
mark) and in USA (US Food and Drug administration approval, 510k
clearance) for several craniomaxillofacial and orthopedicryngology e Head and Neck
-8, FI-20521, Turku, Finland.
onal University, Hanoi.
y Elsevier B.V. on behalf of Vietnamapplications. As a bone cavity ﬁlling material, bioactive glass is
biocompatible [4], induces new bone formation [5] and has sig-
niﬁcant antibacterial effects [6e9]. Antibacterial properties are
related to the pH increase near the BG particles as well as increased
alkali metal and alkali earth metal ion concentration, released from
the BG particles [8].
When the treatment of a challenging chronic middle ear infec-
tion requires canal wall-down mastoidectomy [10], it is sometimes
necessary to ﬁll the bony cavity with a suitable material. When
bioactive glass S53P4 particles are used as a ﬁlling material, BG
particles can be used as such moistened with physiological saline
solution before application, or in tandemwith ﬁbrin glue. The latter
method is currently preferred by ear surgeons, head and neck
surgeons in order to bind the BG particles and allow an easy clinical
application of the material [11e14].
Although a favourable osteoinductive interaction between ﬁbrin
glue and one type of BG has been shown by Abiraman et al. in a
mouse model [15], the data collected via in vivo experimentsNational University, Hanoi. This is an open access article under the CC BY license
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beneﬁt, has been controversial [16]. Only recently, new data has
been published by Zazgyva et al. to support the use of ﬁbrin glue
with BG S53P4 [17]. To our knowledge, there is no data available
addressing the absorption characteristics of ﬁbrin sealant used on
top of BG particles. Also, considering that BG slowly dissolves,
creating a rise in pH of the surrounding liquid environment which
facilitates its antibacterial effects [18], there is a need to understand
the possible impact of using ﬁbrin glue simultaneously with BG not
only on pH values but also on ion concentration of the surrounding
environment. The purpose of this study was to test a hypothesis
that the use of ﬁbrin glue with BG S53P4 particles does not have a
negative inﬂuence on the pH change of simulated body ﬂuid.
2. Materials and methods
The ﬁbrin glue (Tisseel Duo Quick, Baxter AG, Vienna, Austria)
used in this study is a two-component sealant made of pooled
human plasma. The active ingredients consist of human ﬁbrinogen
with ﬁbrinolysis-delaying synthetic aprotinin (sealer protein solu-
tion) and thrombin (thrombin solution). After the frozen, pre-ﬁlled
syringes are warmed, preferably to a 33e37 C temperature using a
water bath or an incubator, the product is ready for application.
The BG S53P4 particles used in this study were produced by
BonAlive Biomaterials Ltd., Turku, Finland. Particle size Varies be-
tween 0.5 and 0.8 mm and the manufacturer lists the following
composition by weight for BG S53P4 particles: silicon dioxide 53%,
sodium oxide 23%, calcium oxide 20%, and phosphate pentoxide 4%.
2.1. Absorption test
The absorption depth of ﬁbrin glue in between BG particles was
studied by ﬁrst creating a solid polyvinyl siloxane mould (Coltene®
Lab-Putty, Coltene/Whaledent AG, Altst€atten, Switzerland) for BG
particles with a cylindrical hole of 5.0 mm in diameter and 10 mm
in depth. Exactly 0.14 g of BG granules, moistened with a physio-
logical saline solution, were applied tightly inside each mould.
Fibrin glue was then incubated in water to temperature of either 9,
21 or 37 C and a drop of ﬁbrin glue was applied on top of the BG-
particle layer covering the whole particle bed surface. As BG par-
ticles ﬁlled the moulds completely, the thickness of each particle
bed before ﬁbrin glue application was approximately 10 mm. The
BGeﬁbrin glue-combination was left to solidify for 24 h at 21 C
room temperature. The penetration depth of ﬁbrin glue was
assessed by removing the solid BGeﬁbrin glue-piece from the
mould and releasing all loose particles from the piece, followed by
the height measurement of the solid piece. This measurement was
used to indicate the penetration depth of ﬁbrin glue into the
interparticle space of BG particles. These solid particles were then
examined and photographed using light microscopy, and at this
stage, the maximum BGeﬁbrin glue-combination thickness was
measured. The penetration depth was measured for ﬁbrin glue
temperatures of 9, 21 and 37 C, using two samples at each
temperature.
2.2. pH test
To investigate the effect of ﬁbrin glue on pH values in a liquid
environment, a two-stage-protocol was used. Using a XS105 Dur
elaboratory scale (Mettler Toledo, United States), 0.14 g (SD 0.00) of
BG S53P4 particles wereweighed for each six test tubes. Then 35ml
of simulated body ﬂuid (SBF) was added, prepared according to the
Kokubo protocol [19], with a seventh control test tube containing
only SBF without BG. Using a Grant OLS200 shaking incubator
(Grant Instruments, United Kingdom) test tubes were kept at 37 Cwith a 100 rpm shaking frequency. For each test tube, SBF pH values
weremeasured at 21 C room temperature after 1, 2, 3, 4 and 7 days,
with a PHM220 Lab pHMeter (Radiometer, Copenhagen, Denmark).
This protocol represented a control series, where only BG was
tested in SBF without ﬁbrin glue.
In a second series, six samples of BG S53P4 particles, weighing
0.14 g (SD 0.00) per sample as well, in tandemwith 0.13 g (SD 0.04)
of ﬁbrin glue, were tested as in the previous description. A feature
of ﬁbrin glue is its rapid coagulation on the tip of the application
cannula, and consequently the exact dosing and direct weighing
presented a challenge. The amount of used ﬁbrin glue was deter-
mined by weighing the two-syringe system before and after
application and thus calculating the weight difference. The tem-
perature of the SBF test tubes was also maintained at 37 C and pH
values were measured accordingly. In addition, as a control, two
samples of ﬁbrin glue alonewithout BGwere incubated in the same
manner to see whether the glue by itself had any effect on SBF pH.
2.3. Ion dissolution test
Dissolution characteristics of BGeﬁbrin glue-combination were
determined for 22 BGeﬁbrin glue-samples. Using a similar protocol
as described above, a cylindrical mould was created for each sam-
ple, 8 mm in diameter and 6 mm in height, and 0.25 g of BG S53P4
particles (SD 0.00) were weighed into each mould. An average of
0.18 g of ﬁbrin glue (SD 0.04), warmed to 37 C temperature was
applied on top of each sample and these BGeﬁbrin glue-mixtures
were left to solidify under a 0.125 mm thick Mylar® polyester ﬁlm
for 18 h at 21 C room temperature. Each sample was then
immersed in 10 ml of SBF and kept in shaking incubator for up to 14
days in the same manner previously described.
After incubation, concentration of calcium, potassium, magne-
sium, sodium, phosphorus and silicon ions in the solution were
measured for samples immersed for 2, 5, 9 and 14 days, using
inductively coupled plasma optical emission spectrometry (ICP-
OES, PerkinElmer Optima 5300 DV, United States). Weights of the
BGeﬁbrin glue-combinations were measured by collecting the
solid sample and any detached BG particles from SBF for this pur-
pose. In addition, pH values (37 C) were measured at 0, 1, 2, 4, 5, 6,
7, 8, 12 and 14 days.
2.4. Statistical analysis
Statistical analysis was performed using SPSS Statistics software
(IBM Corporation, New York, United States). The comparison of the
daily SBF pH change within and between the two groups (BG only
versus BG and ﬁbrin glue) in the 7-day-incubation experiment was
performed with repeated measures analysis of variance (rm
ANOVA). The statistical signiﬁcance was set at the p < 0.05 level.
3. Results
The measured penetration depths of ﬁbrin glue within BG par-
ticles were 4.2 and 6.4 mm for 9 C ﬁbrin glue; 3.2 and 5.6 mm for
21 C ﬁbrin glue and 3.72 and 4.05 mm for 37 C ﬁbrin glue,
respectively (Fig. 1).
When only ﬁbrin glue was kept in SBF, no change in pH was
observed as pH values stayed between 7.48 and 7.49 for both
samples at 1, 2, 3, 5 and 7 days. In contrast, when immersing only
BG S53P4 particles in SBF, the pH rose continuously from the initial
average value of 7.6e8.0 (SD 0.1), measured after seven days of
incubation (Table 1). The pH change was statistically signiﬁcant
(p < 0.001).
When incubating BG S53P4 particles together with ﬁbrin glue,
the average pH of the solution increased after seven days from 7.5
Fig. 1. Light microscopy image of a BG granuleeﬁbrin glue-compound, with a
measured maximum ﬁbrin glue (incubated at 9 C) absorption depth.
J. Sarin et al. / Journal of Science: Advanced Materials and Devices 1 (2016) 482e487484to 8.0 (SD 0.0; Table 2). As in the previous group, the pH change
within this group was statistically signiﬁcant (p < 0.001). When
comparing the pH change pattern between the two test groups on a
daily basis, a statistically signiﬁcant difference was found
(group  time interaction effect, p ¼ 0.008), although the ﬁnal
increment in pH values was of the same order, being 0.4 in the BG-
protocol and 0.5 in the BGeﬁbrin glue-protocol.
As the BGeﬁbrin glue-combos were immersed, a rapid initial
weight reduction took place during the ﬁrst two days, after which
the weight was stable (Fig. 2). At the start of the experiment, the pH
of SBF was in the vicinity of 7.4. This pH value was slightly lower
than the pH of the solutions used for the 7-day test protocols thusTable 1
Bioactive glass S53P4 in simulated body ﬂuid e 7 days incubation with pH monitoring.
No BG (g) After 0 d SBF
storage
After 1 d SBF
storage
After 2 d S
storage
pH t (C) pH t (C) pH
Ref 0 7.57 20.7 7.56 21.3 7.56
1 0.14 7.67 21.2 7.86
2 0.14 7.67 21.0 7.79
3 0.14 7.68 21.0 7.78
4 0.14 7.76 20.7 7.83
5 0.14 7.66 21.0 7.76
6 0.14 7.67 20.8 7.78
Av 0.14 7.6 21 7.7 21 7.8
SD 0.00 0.0 0.2 0.0
RSD 0.6 0.5 0.8 0.5
Table 2
Bioactive glass S53P4 and ﬁbrin glue in simulated body ﬂuid e 7 days incubation with p
No Fibrin glue (g) BG (g) After 0 d SBF
storage
After 1 d SBF
storage
pH t (C) pH t (C)
Ref 0 0 7.48 20.9 7.49 21.5
1 0.1194 0.141 7.76 21.7
2 0.1026 0.141 7.74 21.7
3 0.1133 0.141 7.67 21.8
4 0.1113 0.14 7.75 21.7
5 0.1552 0.141 7.75 21.7
6 0.2039 0.141 7.77 21.8
Av 0.13 0.14 7.5 21 7.7 22
SD 0.04 0.00 0.0 0.1
RSD 28.8 0.2 0.5 0.2reﬂecting typical differences measured for various SBF batches.
Also for these samples, the average pH value rose to around 8.0
(Fig. 2).
Ion concentration changes in SBF during the 14-day incubation
period of the BGeﬁbrin glue-combinations are shown in Fig. 3 and
Table 3. Calcium ion concentration increased from the original
value of 68 mg l1 reaching a near maximum value of 150 mg l1
over a two-day-period, and started to decrease after 5 days. Silicon
ion concentration increased up to 9 days, while phosphorus ion
concentration decreased over time. In addition, the concentration
of other inorganic ions in the solution, K, Mg and Na, stayed at a
relatively constant level.4. Discussion
Results from previous experimental work in the ﬁeld of tissue
engineering seem promising, when the potential beneﬁts of using
two bioactive components, ﬁbrin glue and BG together, are
considered. The endeavour to produce artiﬁcial organs has led the
research, among other things, towards suitable polymer scaffolds
to be used as their base structure. As part of such a scaffold, the
use of a ﬁbrinogen layer seems suitable for generating smooth
muscle cell growth and proliferation in an experimental blood
vessel model by Wang et al. [20]. Gugutkov et al. [21] found a
biologically active ﬁbrinogen network to be a useful part of a 3D
polymer scaffold, as they observed growth and adhesion patterns
of human umbilical endothelial cells in vitro. A ﬁbrinogen solution
has been used successfully by Zhao and Wang as a part of a porous
poly(D,L-lactic-co-glycolic acid) (PLGA) scaffold, manufactured
using a rapid prototyping technique, in which cultured adipose-
derived stem cells were able to grow well in the attached ﬁbrin
layer [22].BF After 3 d SBF
storage
After 4 d SBF
storage
After 7 d SBF
storage
t (C) pH t (C) pH t (C) pH t (C)
21.4 7.57 21.3 7.60 21.2 7.61 20.7
21.5 7.95 21 7.97 21.0 8.07 20.7
21.4 7.83 21 7.93 21.0 7.95 20.9
21.2 7.84 21.1 7.93 21.0 7.95 21.0
20.6 7.90 21.4 7.95 21.0 8.04 21.0
20.6 7.85 21.5 7.88 21.0 7.94 20.9
20.4 7.87 21.6 7.91 20.9 7.96 21.0
21 7.9 21 7.9 21 8.0 21
0.5 0.0 0.3 0.0 0.0 0.1 0.1
2.3 0.6 1.2 0.4 0.2 0.7 0.6
H monitoring.
After 2 d SBF
storage
After 3 d SBF
storage
After 4 d SBF
storage
After 7 d SBF
storage
pH t (C) pH t (C) pH t (C) pH t (C)
7.47 21.5 7.48 21.7 7.49 21.9 7.54 20.9
7.81 21.6 7.89 20.9 7.91 22.0 7.96 21.2
7.78 21.7 7.88 21.4 7.89 22.0 7.94 21.2
7.77 21.8 7.88 21.6 7.91 22.1 8.02 21.2
7.81 21.8 7.88 21.3 7.89 22.1 7.99 21.1
7.86 21.5 7.92 21.6 7.91 22.0 8.00 21.4
7.83 21.6 7.88 21.8 7.90 22.1 8.00 21.5
7.8 22 7.9 21 7.9 22 8.0 21
0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.2
0.4 0.6 0.2 1.5 0.1 0.2 0.4 0.7
Fig. 2. Bioactive glass S53P4 and ﬁbrin glue in simulated body ﬂuid e 14 days incu-
bation with pH monitoring and BGeﬁbrin glue-particle weight measurement.
Table 3
Bioactive glass S53P4 and ﬁbrin glue in simulated body ﬂuid e 14 days incubation
with concentration of ions (mg l1).
Days Ca K Mg Na P Si
0 68 211 35 3239 20 <LOQ
2 150 ± 11 205 ± 10 36 ± 2 3456 ± 142 18 ± 9 39 ± 5
5 151 ± 42 180 ± 16 31 ± 2 3234 ± 202 2 ± 1 56 ± 5
9 86 ± 23 195 ± 6 31 ± 2 3392 ± 128 2 ± 1 67 ± 4
14 90 ± 28 191 ± 10 30 ± 1 3376 ± 146 4 ± 2 58 ± 4
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coating also increases the load bearing capability of a three-
dimensional scaffold, as demonstrated by Gamboa-Martínez et al.
[23]. It seems, generally speaking, that the presence of a ﬁbrinogen
layer as a part of a biocompatible polymer might be very beneﬁcial
as it not only directs the growth of adjacent cells but also improves
mechanical strength.
When BG S53P4 particles are used clinically as a bone cavity
ﬁllingmaterial, the conventional method of choice is tomoisten the
particles with a physiological saline solution before application.
Adhering BG particles partly in ﬁbrin glue, on the other hand, re-
sults in a solid-like mixture that some surgeons ﬁnd easier to
control at the end of the surgery, when the BG-ﬁlled bone cavity is
covered with an appropriate soft tissue.
When using BG S53P4 particles as an obliteration material for
mastoid cavities, the required total volume of the particles can be
up to 20 cm3 [12]. In this study, the ﬁbrin glue penetrated to a depth
of a few Millimeters (4e6 mm) in the bed of the bioactive glass
particles. Thus, if ﬁbrin glue is applied on top of the particles after
ﬁlling the cavity, the glue is likely to adhere to the surface layer only
while the more distal particles are unaffected. From another
perspective, the observation of uneven adherence of ﬁbrin hydrogel
was addressed by Zhao andWang [22], who studied PLGA scaffolds
with 1.35e1.55 mm pore size, rigid in comparison to BG granules.
Consequently, when a stabilizing effect for BG particles via ﬁbrin
glue is pursued in bone cavity ﬁlling, it seems important to startFig. 3. Bioactive glass S53P4 and ﬁbrin glue in simulated body ﬂuapplying the glue with the tip of the application cannula deep in-
side the particle layer to ensure as thorough permeability as
possible. Alternatively, applying BG granules and ﬁbrin glue in a
layer-by-layer fashion might be considered.
When BG S53P4 is used as a bone cavity ﬁlling material, a
feature of particular importance is its extensive antibacterial effect,
as demonstrated by Munukka et al. [8] and Lepp€aranta et al. [9]
in vitro. In fact, even when an extremely challenging bacterial
environment is encountered in vivo, such as in the surgical treat-
ment of osteomyelitis, BG S53P4 seems to function very well in the
operated area [24,25]. In addition, although bacterial bioﬁlms are
especially resistant to any therapeutic intervention, BG S53P4 was
found to suppress the formation of S. aureus bioﬁlm on titanium
discs in a study done by Coraça-Huber et al. [26].
Since the rise in pH is thought to be an essential contributing
factor when it comes to the antibacterial effect of BGs [18], it is
important to know whether the use of ﬁbrin glue in tandem with
BG has any effect on the pH of the surrounding media. The release
of sodium, calcium, phosphate and silicate ions from the BG surface,
the subsequent elevation of pH and the osmotic pressure, and the
following suppression of bacterial growth depends on the size of
the particles in contact with the surrounding liquid environment
[27,28]. The smaller the particles, the faster the ion release rate and
the higher the antibacterial effect. Hence, any measure, such as
adding ﬁbrin glue into the bed of glass particles, reduces the
available responsive BG surface area and might thus be counter-
productive. Yet from the clinical standpoint discussed above, it
might be beneﬁcial to use ﬁbrin glue together with BG particles, if
the glue does not change the anticipated rise of the pH of the
surrounding solution and thus possibly reduce the antibacterial
effect of the BG particles.
In this study, BG S53P4 particles at 4 mg/ml were used without
added ﬁbrin glue. This increased the pH of SBF by 0.4 units during a
7-day incubation period. When these results are compared to those
of other studies, it seems evident that an increase in BG concen-
tration results in higher pH in SBF. By comparison, Massera and
Hupa used lower BG S53P4 particle concentration of 1.5 mg/mlid e 14 days incubation with concentration of ions (mg l1).
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incubation period [28]. When immersing plates of BG S53P4 and
45S5 Bioglass® using the surface area to volume solution ratio Sa/
V ¼ 0.4 cm1, the pH of SBF after one week increased by 0.6 units
and 1.2 units, respectively [29]. When immersing particles of Bio-
glass® 45S5 (100 mg/ml) in SBF containing also glass ﬁber rein-
forced biostable composites, the pH of the solution increased
1 ± 0.2 units from the initial value after one week of incubation in
SBF [30]. Bioglass® 45S5 consists of the same oxides as BG S53P4
but the mutual contents of the oxides are different. In general, 45S5
containing a lower amount of SiO2 shows a more rapid dissolution
and bioactivity than S53P4 [31].
Along with BG concentration, a major contributing factor in the
anticipated pH changes in SBF is the available reactive BG surface
area, as mentioned above. By way of decreasing BG particle size, for
example, amore pronounced pH increase in SBF can be expected, as
demonstrated tangibly by Zhang et al. using seven different BG
particle sizes in their work [27]. Compared to small BG granules or
particles, BG plates have a much smaller reactive surface area per
weight unit, and therefore using BG plates, a more modest pH in-
crease is to be expected relative to actual BG concentration in the
solution [29].
Does ﬁbrin glue suppress or retard the increase in the pH of SBF
when used in tandem with BG S53P4 particles, by decreasing, for
instance, the available reactive surface area? Based on the results in
this study, it seems that coagulated ﬁbrin glue particles alone don't
affect the pH of SBF after seven days of incubation.When ﬁbrin glue
was used simultaneously with BG particles in the 7-day test pro-
tocol, a pH increase of 0.5 units was noticed and this slightly greater
pH increment pattern in BGeﬁbrin glue-group, compared to
several time points to that of the BG-alone-group, was statistically
signiﬁcant (p ¼ 0.008). For the purposes of a dissolution test, a 14-
day test protocol with BG and ﬁbrin glue was also carried out, now
with a BG concentration of 25 mg/ml, and a further 0.6 unit pH
increase was noted at the end of a two week incubation period.
Based on these ﬁndings, it would seem that the use of ﬁbrin glue
withBGwill notdiminish the expectedpH increase of SBF, but rather
seems to strengthen the pH increase, thus possibly increasing the
bioactivity of the product. To some extent, this ﬁnding conﬂicts with
the results from ion dissolution tests discussed later. Whether the
observed pH increment pattern difference between BG- and
BGeﬁbrin glue-groups is also perceptiblewith other concentrations
and incubation periods, not to mention relevant in vivo, remains to
be answered with further studies. In addition, further research is
needed in order to comprehend the inﬂuence of enzymatic activity
in vivowith the interaction of ﬁbrin glue and BG.
From the SBF ion concentration measurements of the 14-day
test protocol with BGeﬁbrin glue-samples, a rapid Ca-ion con-
centration increase can be seen, an observation comparable to
several previous studies [29,30,32], representing the early Ca-ion
dissolution from the BG surface. In general, this increase is fol-
lowed by a decline in SBF Ca-ion concentration, when CaP layer is
growing on BG surface [29]. Massera and Hupa [28] observed with
BG S53P4 particles incubated in SBF with a concentration of
1.5 mg/ml, a steep early increase in Ca-ion concentration reaching
its maximum after 30 h, followed by a Ca-ion concentration
decline, reaching a relatively steady state after 70 h. In contrast, in
this study with BGeﬁbrin glue-combinations at a concentration of
25 mg/ml, a slightly slower increase with a prolonged Ca-ion
concentration increment was found, which only started to
decrease from peak levels after 5 days reaching eventually stable
levels after 9 days. An explanation for such a difference between
these two studies might be the ﬁbrin glue's ability to adhere to BG,
thus forming a diffusion barrier between the glass and the solu-
tion. Accordingly, at least some of the particle surfaces are lessprone to react and release ions in the solution during the early
phase of incubation. This slows down the CaP layer formation,
thus prolonging the process of Ca-ion consumption from SBF in
later phase. The changes in the sample mass as a function of time
suggest further that already after two days of incubation most of
the ﬁbrin glue has dissolved making the surfaces of all particles
available for reactions in vitro.
The concentration of Si in the BGeﬁbrin glue-protocol
increased, reaching its highest levels after 9 days of incubation. The
observed value is typical for a test done in static solutions and
suggests that the solution is saturated with respect to Si. In the
same fashion as discussed above, this took again considerably more
time compared to earlier work using only BG S53P4 particles
without ﬁbrin glue [28]. P-ion levels declined, whereas other
measured ion concentrations, namely K, Mg and Na, stayed on a
relatively constant level. The slight decreases in the concentrations
of these ions suggest that they are incorporated into the CaP layer.
Previous studies have shown comparable characteristics in ion
concentration behavior [28,30]. The results further suggest that the
dissolution of phosphate from the glass is a rate determining step
for the CaP formation. In vivo, the continuous ﬂow of ﬂuids is likely
to enhance the dissolution reactions. However, considering that the
ﬁbrin glue partly occupies free spaces between the particles, the pH
of the solution around some glass particles can increase locally. This
may affect the dissolution rate of the glass.
Possible error sources in our study include the encountered
difﬁculties in measuring the exact amount of applied ﬁbrin glue, as
opposed to more accurate weighing of BG particles. Likewise, when
some partly dissolved BGeﬁbrin glue-combinations were weighed
during incubation in order to determine the weight loss, the ac-
quired weight measurements should be considered somewhat
rough estimates, as BG particles became increasingly detached and
thus weren't a single, clearly deﬁned solid unit. Expectedly for each
test protocol, the starting pH of SBF varied between 7.4 and 7.6,
which reﬂects the difﬁculty in getting absolute constant test con-
ditions for each test series owing to the slight differences between
SBF batches. Hence, more emphasis should be put on the observed
pH changes than merely on the ﬁnal pH values at the end of the
experiments.
5. Conclusions
Degradation of ﬁbrin glue (Tisseel) does not seem to have any
signiﬁcant effect on the pH of SBF when used at low concentrations.
When BG S53P4 particles were partly covered by ﬁbrin glue, a
slightly greater rise in the pH after 7 days of incubation was
observed compared to the rise induced by BG particles alone. Thus,
the concomitant use of ﬁbrin glue with BG S53P4 particles is un-
likely to diminish the pH-rise-dependent antibacterial effects when
compared to those of BG particles alone, suggesting these two
bioactive materials can well be used simultaneously. However, our
results from dissolution measurements suggest delayed ion con-
centration changes of BGeﬁbrin glue-samples in SBF, compared to
previous studies using BG individually, an effect probably mediated
by early ﬁbrin glue adherence on BG surface. When ﬁbrin glue is
used in tandemwith BG particles, there seems to be the noticeable
glue penetrationwith adherence, making BG particles easier to use.
However, one should consider starting the application of the glue
deep inside the particle layer to have a thorough permeability, if
desired.
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